Roivant Sciences Ltd. (ROIV)
USD 10.19
(3.35%)
USD 10.19
(3.35%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 499.74 Million USD | 3.81% |
| 2023 | 481.4 Million USD | 69.57% |
| 2022 | 283.89 Million USD | 15.88% |
| 2021 | 244.97 Million USD | 35.43% |
| 2020 | 180.88 Million USD | 26.34% |
| 2019 | 143.17 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 492.63 Million USD | -24.15% |
| 2024 Q2 | 497.97 Million USD | -86.09% |
| 2024 FY | 499.74 Million USD | 3.81% |
| 2024 Q3 | 506.57 Million USD | 1.73% |
| 2024 Q4 | 499.74 Million USD | -1.35% |
| 2023 Q1 | 489.27 Million USD | 72.35% |
| 2023 Q2 | 477.29 Million USD | -2.45% |
| 2023 Q4 | 481.4 Million USD | 0.37% |
| 2023 Q3 | 479.63 Million USD | 0.49% |
| 2023 FY | 481.4 Million USD | 69.57% |
| 2022 Q2 | 276.6 Million USD | 4.91% |
| 2022 FY | 283.89 Million USD | 15.88% |
| 2022 Q4 | 283.89 Million USD | 2.35% |
| 2022 Q1 | 263.66 Million USD | 7.63% |
| 2022 Q3 | 277.37 Million USD | 0.28% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q1 | - USD | 0.0% |
| 2021 Q4 | 244.97 Million USD | 0.0% |
| 2021 FY | 244.97 Million USD | 35.43% |
| 2020 Q4 | - USD | 0.0% |
| 2020 FY | 180.88 Million USD | 26.34% |
| 2019 FY | 143.17 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Agenus Inc. | 350.24 Million USD | -42.685% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -3359.907% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -1718.261% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -326.432% |
| MiMedx Group, Inc. | 48.09 Million USD | -939.001% |
| Novavax, Inc. | 280.63 Million USD | -78.078% |
| Seer, Inc. | 28.25 Million USD | -1668.46% |
| Acelyrin, Inc. | 1.19 Million USD | -41755.025% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -118.049% |
| IO Biotech, Inc. | 2.49 Million USD | -19938.051% |
| Ardelyx, Inc. | 55.98 Million USD | -792.696% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -604.11% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -2292.949% |
| Fortress Biotech, Inc. | 88.59 Million USD | -464.102% |
| Fortress Biotech, Inc. | 88.59 Million USD | -464.102% |
| Geron Corporation | 85.89 Million USD | -481.787% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -333.919% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -7519.286% |
| Incyte Corporation | 38.28 Million USD | -1205.271% |
| Innoviva, Inc. | 449.07 Million USD | -11.284% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| ChromaDex Corporation | 3.27 Million USD | -15150.198% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -8006.229% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| NextCure, Inc. | 6.6 Million USD | -7466.223% |
| Onconetix, Inc. | 9.88 Million USD | -4955.235% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -157053.774% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -61719.367% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -17300.731% |
| Vaxcyte, Inc. | 29.22 Million USD | -1610.064% |
| Precigen, Inc. | 7.09 Million USD | -6941.694% |
| Pharming Group N.V. | 171.54 Million USD | -191.322% |
| ContextLogic Inc. | 6 Million USD | -8229.15% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -51526.963% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -2242.83% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -724.954% |
| AlloVir, Inc. | 27.42 Million USD | -1721.973% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -352.843% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -172439.644% |
| Summit Therapeutics Inc. | 106.09 Million USD | -371.021% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -30465.688% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -7950.081% |
| Senti Biosciences, Inc. | 37.66 Million USD | -1226.791% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -392.927% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -632.448% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -6426.356% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -1305.555% |
| Chimerix, Inc. | 2.14 Million USD | -23209.188% |
| PDS Biotechnology Corporation | 23.85 Million USD | -1995.242% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -2869.394% |
| CRISPR Therapeutics AG | 238.63 Million USD | -109.422% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -1455.978% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -259.454% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -1650.986% |
| Precision BioSciences, Inc. | 31.26 Million USD | -1498.276% |
| Dyadic International, Inc. | 136.92 Thousand USD | -364869.437% |
| Elevation Oncology, Inc. | 30.13 Million USD | -1558.257% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -9061.302% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -379.688% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 81.371% |
| Aptorum Group Limited | 3.36 Million USD | -14762.879% |
| Bicycle Therapeutics plc | 44.95 Million USD | -1011.64% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -494700.99% |
| Clearside Biomedical, Inc. | 43 Million USD | -1062.18% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -80245.111% |
| GT Biopharma, Inc. | 58 Thousand USD | -861536.207% |
| Alkermes plc | 290.73 Million USD | -71.895% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -998.108% |
| Jaguar Health, Inc. | 35.86 Million USD | -1293.611% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -23473.066% |
| AbCellera Biologics Inc. | 77.38 Million USD | -545.837% |
| PureTech Health plc | 25.51 Million USD | -1858.878% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -110814.595% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -1211.539% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -55059.934% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -3751.334% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -7014.878% |
| AnaptysBio, Inc. | 17.81 Million USD | -2705.372% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -2470.064% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -622035.494% |
| Molecular Templates, Inc. | 12.23 Million USD | -3986.255% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | -271.55% |
| Vaxxinity, Inc. | 15.16 Million USD | -3194.759% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -1855.506% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -30132.849% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -1936.301% |
| Structure Therapeutics Inc. | 5.45 Million USD | -9064.66% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -105110.316% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -7211.617% |
| ImmuCell Corporation | 11.96 Million USD | -4075.256% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -213038.938% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -233427.57% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Opthea Limited | 200.62 Million USD | -149.091% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -4972.564% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -705.073% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -382.681% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -137.816% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -13949.733% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -29523.533% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -166087.474% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -1895.643% |
| Aptose Biosciences Inc. | 1 Million USD | -49389.605% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -5773340.388% |
| Soligenix, Inc. | 3.49 Million USD | -14200.766% |
| Century Therapeutics, Inc. | 48.17 Million USD | -937.448% |
| Kura Oncology, Inc. | 17.2 Million USD | -2805.517% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -440.661% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -316196.835% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -23144.14% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -3476.277% |
| Autolus Therapeutics plc | 52.96 Million USD | -843.51% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -9037.85% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -1094.343% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -117.82% |
| GRI Bio, Inc. | 14 Thousand USD | -3569535.714% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -3922.448% |
| IGM Biosciences, Inc. | 40.5 Million USD | -1133.765% |
| INmune Bio, Inc. | 10.43 Million USD | -4688.244% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -178.213% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -8360.2% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -611737.659% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -60340.543% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -865.232% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -757.482% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -763.542% |
| Coherus BioSciences, Inc. | 480.84 Million USD | -3.932% |
| Verastem, Inc. | 41.55 Million USD | -1102.563% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -9154.611% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -4294.557% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -4992.724% |
| Histogen Inc. | 4.62 Million USD | -10712.397% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 3.37 Million USD | -14689.849% |
| Organovo Holdings, Inc. | 1.39 Million USD | -35750.0% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 46 Million USD | -986.37% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -9521.66% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -2252.978% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -2340644.731% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -490.804% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -238991.475% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -1553.922% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -307784.572% |
| Apollomics, Inc. | 4.66 Million USD | -10621.927% |
| Amarin Corporation plc | 8.73 Million USD | -5619.915% |
| Mesoblast Limited | 118.92 Million USD | -320.229% |
| Turnstone Biologics Corp. | 3.21 Million USD | -15449.129% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -490.204% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -202227.53% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -412.001% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -163.103% |
| Better Therapeutics, Inc. | 14.88 Million USD | -3258.528% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -1532.42% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -350.517% |
| NLS Pharmaceutics AG | 1.63 Million USD | -30489.149% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -8052.512% |
| Gritstone bio, Inc. | 104.77 Million USD | -376.974% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -17837.868% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -1022508.963% |
| Avid Bioservices, Inc. | 207.83 Million USD | -140.456% |
| Insmed Incorporated | 1.2 Billion USD | 58.492% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.71 Million USD | -7346.714% |
| OmniAb, Inc. | 25.56 Million USD | -1855.123% |
| Alector, Inc. | 38.91 Million USD | -1184.108% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -133.597% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 15.15 Million USD | -3198.456% |
| Revance Therapeutics, Inc. | 478.43 Million USD | -4.455% |
| Aura Biosciences, Inc. | 19.55 Million USD | -2455.346% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -691.155% |
| Immunic, Inc. | 1.33 Million USD | -37362.444% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -1474.905% |
| Veracyte, Inc. | 12.63 Million USD | -3856.841% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 22.503% |
| FibroGen, Inc. | 170.45 Million USD | -193.185% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -5403.238% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -244981.923% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 91.379% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -1350572.973% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -11694.878% |
| TG Therapeutics, Inc. | 110.79 Million USD | -351.057% |
| Galecto, Inc. | 249 Thousand USD | -200602.41% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -29896.939% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 70.218% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -6729.971% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -9159.755% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -17837.868% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -1759.116% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -1008.755% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -35118.393% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -1004.759% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -1057.657% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -936.2% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 41.117% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -48542.201% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -4461.835% |
| NexImmune, Inc. | 68.8 Thousand USD | -726184.352% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -3520746.837% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 81.511% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -127386.339% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -7136.447% |
| Ainos, Inc. | 5.96 Million USD | -8280.05% |
| Pluri Inc. | 29.61 Million USD | -1587.657% |
| Prothena Corporation plc | 11.83 Million USD | -4122.636% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -1880.38% |
| Celularity Inc. | 65.41 Million USD | -663.944% |
| Rallybio Corporation | 392 Thousand USD | -127386.99% |
| Cue Biopharma, Inc. | 14.69 Million USD | -3300.81% |
| MeiraGTx Holdings plc | 89.26 Million USD | -459.855% |
| Omeros Corporation | 338.28 Million USD | -47.732% |
| Humacyte, Inc. | 58.1 Million USD | -760.064% |
| Immunocore Holdings plc | 84.03 Million USD | -494.713% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -26869.725% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -10147.058% |
| Blueprint Medicines Corporation | 774.12 Million USD | 35.443% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -9859.127% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -708.42% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -380.085% |
| Pulmatrix, Inc. | 8.75 Million USD | -5607.503% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -7124.939% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -3508.296% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -333.261% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -1484.091% |
| Cytokinetics, Incorporated | 755.77 Million USD | 33.876% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -3633.929% |
| Nutriband Inc. | 241.28 Thousand USD | -207019.796% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -9041.193% |
| Vor Biopharma Inc. | 35.66 Million USD | -1301.427% |
| Evogene Ltd. | 1.13 Million USD | -43814.675% |
| ProKidney Corp. | 4.41 Million USD | -11224.473% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -40662.561% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -905816.795% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 71.276% |
| CorMedix Inc. | 667.63 Thousand USD | -74753.961% |
| BioLineRx Ltd. | 11.59 Million USD | -4211.526% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -1184.042% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -595.961% |
| Atai Life Sciences N.V. | 16.47 Million USD | -2933.194% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -20289.629% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -73936.889% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -991.799% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -768744.615% |
| MediciNova, Inc. | 215.92 Thousand USD | -231344.569% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -19930.02% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -39530.286% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -168.146% |
| Biomea Fusion, Inc. | 10.29 Million USD | -4753.817% |
| PTC Therapeutics, Inc. | 415.02 Million USD | -20.414% |
| Mereo BioPharma Group plc | 5.95 Million USD | -8296.321% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -13820.585% |
| Absci Corporation | 15.95 Million USD | -3031.848% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -5355.18% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -3306.373% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -1722.904% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -3976.921% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -3896.074% |
| Allakos Inc. | 41.46 Million USD | -1105.231% |
| Imunon, Inc. | 1.62 Million USD | -30659.198% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -4518.325% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -330859.603% |
| BioAtla, Inc. | 2.46 Million USD | -20215.0% |
| NLS Pharmaceutics AG | 1.63 Million USD | -30489.149% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -442155.752% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -425.382% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -8910.981% |
| XOMA Corporation | 124.45 Million USD | -301.566% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -2539.566% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -1057.711% |
| aTyr Pharma, Inc. | 15.09 Million USD | -3210.692% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -4386.883% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -1818.938% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -2274.33% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -143094.556% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -152965.763% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -30527.036% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 66.667% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -304686.329% |
| UroGen Pharma Ltd. | 100.21 Million USD | -398.682% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -173.462% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -144193.502% |
| Orgenesis Inc. | 22.62 Million USD | -2109.226% |
| Entera Bio Ltd. | 390 Thousand USD | -128040.769% |
| GH Research PLC | 343 Thousand USD | -145599.417% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -163752.131% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -51261.665% |
| Xencor, Inc. | 83.43 Million USD | -498.975% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -289319.307% |
| Replimune Group, Inc. | 75.86 Million USD | -558.7% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -40721.629% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -5214.217% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -304686.329% |
| Portage Biotech Inc. | 47 Thousand USD | -1063195.745% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -39530.286% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -20576.417% |
| OncoCyte Corporation | 2.86 Million USD | -17318.926% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -38365.428% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -331840.035% |
| Purple Biotech Ltd. | 351 Thousand USD | -142278.632% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -15719.848% |
| scPharmaceuticals Inc. | 40.26 Million USD | -1141.027% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 51.19 Million USD | -876.206% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -351835.915% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -9453.604% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -1769.059% |
| Curis, Inc. | 2.79 Million USD | -17786.507% |
| Daré Bioscience, Inc. | 5.31 Million USD | -9297.055% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -23291.572% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -88351.15% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -2886.964% |
| BeiGene, Ltd. | 930.18 Million USD | 46.274% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -3115.371% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -468.258% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -43699.211% |
| Erasca, Inc. | 55.85 Million USD | -794.662% |
| bluebird bio, Inc. | 330.32 Million USD | -51.29% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 55.926% |
| DBV Technologies S.A. | 14.38 Million USD | -3375.064% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -19873.981% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -10661.176% |
| Travere Therapeutics, Inc. | 404.78 Million USD | -23.461% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -985.491% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -10742.894% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -19559.677% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -2550.766% |
| MacroGenics, Inc. | 33.97 Million USD | -1371.105% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 20.92 Million USD | -2288.401% |
| Prime Medicine, Inc. | 13.63 Million USD | -3565.73% |
| Aditxt, Inc. | 18.21 Million USD | -2643.163% |
| Adagene Inc. | 22.3 Million USD | -2140.337% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -3165.693% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 18.204% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -2362.667% |
| SciSparc Ltd. | 76 Thousand USD | -657464.474% |
| Vericel Corporation | 88.14 Million USD | -466.975% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -509.325% |
| Generation Bio Co. | 97.89 Million USD | -410.5% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -151799.392% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -1875.449% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -142.696% |
| Invivyd, Inc. | 2.16 Million USD | -22983.095% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -834.704% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -14182286.278% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -8915.858% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -793152.381% |
| 2seventy bio, Inc. | 256.67 Million USD | -94.703% |
| ADMA Biologics, Inc. | 141.41 Million USD | -253.384% |
| Clene Inc. | 32.16 Million USD | -1453.898% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -8804.763% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -22667.608% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -886.243% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -103745.027% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -158.68% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -1558.863% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -2806.024% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -301.276% |
| Evaxion Biotech A/S | 10.86 Million USD | -4497.643% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -499.298% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -567.159% |
| Trevena, Inc. | 35.23 Million USD | -1318.412% |
| Surrozen, Inc. | 3.37 Million USD | -14689.849% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -7593.18% |
| Cingulate Inc. | 3.13 Million USD | -15840.454% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -1218800.0% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -1751.608% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -99669.616% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -82777.114% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -773.611% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -107372.903% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -1667.646% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -2371.68% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -32038.199% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -39562.619% |
| Statera Biopharma, Inc. | 16.26 Million USD | -2973.272% |
| ImmunityBio, Inc. | 883.67 Million USD | 43.447% |
| Korro Bio, Inc. | 33.2 Million USD | -1404.951% |
| Kineta, Inc. | 1.31 Million USD | -37846.014% |
| BioVie Inc. | 6.11 Million USD | -8077.261% |
| Codexis, Inc. | 22.36 Million USD | -2134.614% |
| Celularity Inc. | 65.41 Million USD | -663.944% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -866.109% |
| Celcuity Inc. | 37.44 Million USD | -1234.576% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -222703.834% |
| Cibus, Inc. | 24.62 Million USD | -1929.767% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -130382.768% |
| IN8bio, Inc. | 4.89 Million USD | -10113.55% |
| Kodiak Sciences Inc. | 181.63 Million USD | -175.144% |
| Annexon, Inc. | 31.35 Million USD | -1493.841% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -566.012% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -21238.557% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -12704.228% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 65.618% |
| Eyenovia, Inc. | 16.1 Million USD | -3002.536% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -348.246% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -50635.939% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -4261.953% |
| Arcellx, Inc. | 97.62 Million USD | -411.907% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -23154.956% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -1784.921% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -16010.542% |
| Moolec Science SA | 2.64 Million USD | -18792.038% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -1654.305% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -7816.189% |
| Royalty Pharma plc | 6.13 Billion USD | 91.855% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -20705.537% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -433506.643% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -1377.236% |
| Humacyte, Inc. | 58.1 Million USD | -760.064% |
| 89bio, Inc. | 27.1 Million USD | -1743.548% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -3661.471% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -19739.182% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -37250.448% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -371.177% |
| Notable Labs, Ltd. | 2.04 Million USD | -24289.898% |
| Liquidia Corporation | 3.5 Million USD | -14166.315% |
| Mustang Bio, Inc. | 2.49 Million USD | -19905.965% |
| Immunovant, Inc. | 138 Thousand USD | -362036.957% |
| Quantum-Si incorporated | 15.3 Million USD | -3165.693% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -5630.409% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -124837.25% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -830.493% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -611737.659% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -4483.592% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -237322.858% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -246081.773% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -2318.804% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -123907.196% |
| PepGen Inc. | 20.1 Million USD | -2385.819% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -86964.286% |
| United Therapeutics Corporation | 700 Million USD | 28.607% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 26.26 Million USD | -1802.718% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.46 Million USD | -11097.705% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 886 Thousand USD | -56305.079% |
| XOMA Corporation | 124.45 Million USD | -301.566% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -182290.146% |
| Bionomics Limited | 239.61 Million USD | -108.561% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -24469.776% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -3664.304% |
| uniQure N.V. | 138.4 Million USD | -261.067% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -485.029% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -48325.291% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -50635.939% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -5403.238% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -28506.125% |
| Altimmune, Inc. | 671 Thousand USD | -74378.241% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | -12.288% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -3664.304% |
| Compugen Ltd. | 1.35 Million USD | -36891.044% |
| Peak Bio, Inc. | 10.72 Million USD | -4561.052% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -1068.566% |
| Benitec Biopharma Inc. | 284 Thousand USD | -175867.958% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -491.034% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -2408.654% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 11.77 Million USD | -4142.712% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -446.425% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -2408.654% |
| Instil Bio, Inc. | 86.05 Million USD | -480.739% |
| argenx SE | 20 Million USD | -2398.745% |
| Immunome, Inc. | 1.65 Million USD | -30187.818% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -28737.219% |
| Verona Pharma plc | 51.32 Million USD | -873.619% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -5010.953% |
| Shattuck Labs, Inc. | 4.2 Million USD | -11793.122% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -137952.21% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -11852.858% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -85327.179% |
| Moolec Science SA | 2.64 Million USD | -18792.038% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -1554.292% |
| Design Therapeutics, Inc. | 3.05 Million USD | -16285.213% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -190643.893% |
| NeurAxis, Inc. | 224.26 Thousand USD | -222743.574% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -3412.433% |
| Lumos Pharma, Inc. | 6.58 Million USD | -7489.203% |
| Achilles Therapeutics plc | 4.61 Million USD | -10728.797% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -5010.953% |
| 180 Life Sciences Corp. | 1.32 Million USD | -37757.794% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -2825.91% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -32038.199% |
| Nutriband Inc. | 241.28 Thousand USD | -207019.796% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -4793.263% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -60402.3% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | -33.722% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -1560.351% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -13414.524% |
| Palisade Bio, Inc. | 369 Thousand USD | -135333.333% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -120321.446% |
| Beam Therapeutics Inc. | 173.17 Million USD | -188.584% |
| Neurogene Inc. | 16.25 Million USD | -2974.432% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -62.181% |
| AEON Biopharma, Inc. | 278 Thousand USD | -179665.827% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -149078.806% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -467431.411% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -558.761% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -717.826% |
| Athira Pharma, Inc. | 1.58 Million USD | -31429.905% |
| Vaccinex, Inc. | 247 Thousand USD | -202227.53% |
| HCW Biologics Inc. | 6.45 Million USD | -7645.912% |
| XOMA Corporation | 124.45 Million USD | -301.566% |
| Nektar Therapeutics | 230.4 Million USD | -116.904% |
| Arvinas, Inc. | 3.4 Million USD | -14598.5% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -30527.036% |
| Merus N.V. | 12.16 Million USD | -4009.102% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -289.128% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -3517.699% |
| Rezolute, Inc. | 2.22 Million USD | -22330.386% |
| Clene Inc. | 32.16 Million USD | -1453.898% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -285384.396% |
| BeyondSpring Inc. | 3.99 Million USD | -12409.362% |
| Synlogic, Inc. | 17.27 Million USD | -2792.903% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -38342.231% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -1427754.286% |
| Peak Bio, Inc. | 10.72 Million USD | -4561.052% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -862.481% |
| Krystal Biotech, Inc. | 8.09 Million USD | -6074.315% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -182.319% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -6981.607% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -365764.533% |
| MannKind Corporation | 382.37 Million USD | -30.695% |
| Ikena Oncology, Inc. | 10.73 Million USD | -4554.023% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -122088.02% |
| Gossamer Bio, Inc. | 212.46 Million USD | -135.216% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -287112.069% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -5355.18% |
| Legend Biotech Corporation | 328.67 Million USD | -52.051% |
| Mural Oncology plc | 15 Million USD | -3229.662% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -953.745% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -23686.245% |
| Champions Oncology, Inc. | 7.43 Million USD | -6626.097% |
| REGENXBIO Inc. | 89.29 Million USD | -459.692% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -58370.897% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -90273.466% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -9130.68% |
| Vaxart, Inc. | 26.51 Million USD | -1784.85% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -3091.783% |
| Cellectis S.A. | 92.85 Million USD | -438.215% |
| Longeveron Inc. | 2.04 Million USD | -24385.497% |
| Repare Therapeutics Inc. | 3.41 Million USD | -14555.396% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 64.222% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -972.607% |
| Revolution Medicines, Inc. | 87.94 Million USD | -468.258% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -288772.254% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -12542.272% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -157549.527% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -285470.857% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 38.18% |
| Denali Therapeutics Inc. | 52.24 Million USD | -856.622% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -3369.163% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -36271.834% |
| Cingulate Inc. | 3.13 Million USD | -15840.454% |
| Passage Bio, Inc. | 26.29 Million USD | -1800.62% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -7398.11% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -122387.5% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -55800.336% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -2330.568% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -39562.619% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -20288.59% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -15902.209% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -61521.332% |
| OmniAb, Inc. | 25.56 Million USD | -1855.123% |
| Anew Medical, Inc. | 1.6 Million USD | -31037.009% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -1589.319% |
| Lipocine Inc. | 17.16 Thousand USD | -2911172.282% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -4194.114% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -1343.193% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -8360.2% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -774.1% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -246081.773% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -9575.682% |
| Ocugen, Inc. | 6.94 Million USD | -7099.957% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -3437.044% |
| Q32 Bio Inc. | 1.31 Million USD | -37817.223% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -74267.411% |
| Alumis Inc. Common Stock | 32.58 Million USD | -1433.913% |
| Equillium, Inc. | 824 Thousand USD | -60549.15% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -5404.45% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -166036.646% |
| Galera Therapeutics, Inc. | 152.29 Million USD | -228.137% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -877.256% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -64379.748% |
| Dominari Holdings Inc. | 3.02 Million USD | -16404.26% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -528807.68% |
| vTv Therapeutics Inc. | 529 Thousand USD | -94370.51% |
| Bio-Techne Corporation | 419.53 Million USD | -19.119% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -594.134% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -158.18% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -2859.196% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -2095.541% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -8149.406% |
| Nkarta, Inc. | 88.33 Million USD | -465.717% |
| BioCardia, Inc. | 1.31 Million USD | -37903.726% |
| Iterum Therapeutics plc | 19.5 Million USD | -2461.633% |